Pancreatic Cancer Research

ResearcherNational Cancer CenterActive in the last 2 years

Tae Hyun Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8413-3385; OpenAlex author ID A5100438974. Sources: OpenAlex.

Their work

Papers
15 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: 2 papers · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 15

  1. Optimization of electrode position in electric field treatment for pancreatic cancer. Co-author DOI 10.1186/s12876-025-03807-0↗
  2. Mutant KRAS and GATA6 Stratify Survival in Patients Treated with Chemotherapy for Pancreatic Adenocarcinoma: A Prospective Cohort Study. Co-author DOI 10.3390/cancers17050896↗
  3. Impact of sarcopenia on survival of pancreatic cancer patients treated with concurrent chemoradiotherapy. Co-author DOI 10.1177/0300891620937795↗
  4. Efficacy and feasibility of proton beam radiotherapy using the simultaneous integrated boost technique for locally advanced pancreatic cancer. Co-author DOI 10.1038/s41598-020-78875-1↗
  5. Cytopathological results of initial endoscopic ultrasound-guided fine needle aspiration for primary mass and prognosis in pancreatic cancer patients. Co-author DOI 10.1111/cyt.12675↗
  6. Comprehensive Cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic Cancer Patients Receiving Neoadjuva… Co-author DOI 10.5009/gnl18355↗
  7. Effectiveness and Safety of Simultaneous Integrated Boost-Proton Beam Therapy for Localized Pancreatic Cancer. Co-author DOI 10.1177/1533033818783879↗
  8. Effectiveness and feasibility of concurrent chemoradiotherapy using simultaneous integrated boost-intensity modulated radiotherapy with and without induction c… First author DOI 10.3857/roj.2018.00073↗
  9. Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Radiotherapy with Concurrent Gemcitabine fo… Co-author DOI 10.4143/crt.2016.495↗
  10. Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized trial. Co-author DOI 10.1016/j.pan.2016.09.001↗
  11. Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer. Co-author DOI 10.1186/1748-717x-8-160↗
  12. Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study. Co-author DOI 10.3346/jkms.2013.28.2.247↗
  13. Multiple primary malignant neoplasms in pancreatic cancer patients: a single-center experience in Korea. Co-author DOI 10.1097/mpa.0b013e3182374d65↗
  14. CA 19-9 level as indicator of early distant metastasis and therapeutic selection in resected pancreatic cancer. Co-author DOI 10.1016/j.ijrobp.2010.10.011↗
  15. Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and therapeutic selection in localized and u… Co-author DOI 10.1016/j.ijrobp.2011.02.063↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Woo Jin Lee · 13 shared papers, 2011–2025 · strength 0.93
  2. Sang Myung Woo · 13 shared papers, 2011–2025 · strength 0.93
  3. Sung‐Sik Han · 12 shared papers, 2011–2020 · strength 0.71
  4. Sang‐Jae Park · 12 shared papers, 2011–2020 · strength 0.71
  5. Yun‐Hee Kim · 4 shared papers, 2016–2025 · strength 0.43
  6. Sun‐Young Kong · 3 shared papers, 2017–2025 · strength 0.37
  7. Dae Yong Kim · 6 shared papers, 2011–2020 · strength 0.34
  8. Eun Kyung Hong · 7 shared papers, 2011–2019 · strength 0.33
  9. Sangcheol Kim · 1 shared paper, 2025 · strength 0.27
  10. Myonggeun Yoon · 1 shared paper, 2025 · strength 0.27
  11. Eun Sang Oh · 3 shared papers, 2018–2020 · strength 0.26
  12. Mi Rim Lee · 1 shared paper, 2025 · strength 0.22
  13. Hyeong Min Park · 1 shared paper, 2025 · strength 0.22
  14. Jung Won Chun · 1 shared paper, 2025 · strength 0.22
  15. Won Kyung Cho · 1 shared paper, 2021 · strength 0.16
  16. Hee Chul Park · 1 shared paper, 2021 · strength 0.16
  17. Eui Kyu Chie · 1 shared paper, 2021 · strength 0.16
  18. Jeong Il Yu · 1 shared paper, 2021 · strength 0.16
  19. Kyong‐Ah Yoon · 2 shared papers, 2017–2019 · strength 0.16
  20. Jung Hwan Lee · 1 shared paper, 2019 · strength 0.10
  21. Joong‐Won Park · 3 shared papers, 2011–2012 · strength 0.08
  22. Hyun Jung Kim · 1 shared paper, 2018 · strength 0.07
  23. Min Kyeong Kim · 1 shared paper, 2017 · strength 0.06
  24. So Young Kim · 1 shared paper, 2016 · strength 0.05
  25. Tae Yoo · 2 shared papers, 2011 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.